HBIG,无环鸟苷,干扰素联合对慢性乙型肝炎抗病毒效应观察

本文报道血清ＨＢＶ复制标志阳性的慢乙肝５４例,随机分为治疗组及对照组各２７例进行ＨＢＩＧ、无环鸟苷、干扰素联合近、远期抗病毒效应观察。治疗组为无环鸟苷第一周按２５～２０ｍｇ／ｋｇ／ｄ计后改１７～１５ｍｇ／ｋｇ／ｄ×５３天,共６０天;人白细胞干扰素１×１０６Ｕ肌注每周３次×４周,后改１．０×１０６Ｕ肌注每周２次×６周,共１０周;ＨＢＩＧ４００Ｕ肌注隔日１次,共１０周,对照组仅给予一般“保肝”药物。其中治疗组１８例,对照组１９例进行治后半年到２年追踪观察,结果近、远期ＨＢｃＡｇ、ＤＮＡＰ、ＨＢＶ－ＤＮＡ阴转率治疗组均高于对照组,其中治疗组近、远期ＨＢｃＡｇ,ＨＢＶ－ＤＮＡ阴转率均达４０％以上,明显高于对照组（Ｐ＜０．０５～０．０１）,治疗组近、远期各有４例及２例ＨＢｓＡｇ阴转,而对照组则无一例阴转,从近、远期综合抗病毒效应观察,治疗组全阴率分别为３３．３％、４４．４％,而对照组分别为３．７９％及０％,Ｐ＜０．０１,治疗组无明显毒副反应。对比单用无环鸟苷,全阴率３１．８％;无环鸟苷加干扰素两药联合全阴率３７．５％,均有所提高,达到４４．４％,值得进一步研究。     

应用重离子束苏制核微孔滤膜除菌除支原体的研究

本文采用苏制核微孔滤膜进行了除菌、除支原体实验研究,核孔膜孔径分别为０．０７、０．１、０．５、０．７及１．５微米,采用的菌种为白色葡萄球菌、链球菌和大肠杆菌,支原体为解脲脲原体,实验结果表明：０．０７及０．１微米的核孔膜可完全滤除细菌及支原体,０．５微米的核孔膜可滤除绝大部分细菌,不能滤除支原体,１．５微米的核孔膜只能滤除少量细菌。     

不同代次牛肾原代细胞培养轮状病毒的比较研究

口服轮状病毒活疫苗(LLR株)生产用细胞基质为新生小牛肾原代细胞。原始的初代细胞(P0)产量小,一对牛肾平均生产7瓶细胞。将原始的初代细胞传代可使细胞产量显著增加,传代后(P2代)细胞产量可由7瓶增加为96~112瓶,细胞核型检查传至P5代的细胞染色体数目与初代细胞一致。细胞培养物均一性提高。P0代与P2代细胞病毒培养物滴度分别在6.2±1.5和6.5±0.5lgCCID50/ml,使用P2代细胞培养病毒,产量增加10~15倍。提高了疫苗生产的可控性和质量,生产规模显著放大,经济效益明显。     

Predator-induced morphology enhances escape locomotion in crucian carp

Fishes show a remarkable diversity of shapes which have been associated with their swimming abilities and anti-predator adaptations. The crucian carp (Carassius carassius) provides an extreme example of phenotypic plasticity in body shape which makes it a unique model organism for evaluating the relationship between body form and function in fishes. In crucian carp, a deep body is induced by the presence of pike (Esox lucius), and this results in lower vulnerability to gape-limited predators, such as pike itself. Here, we demonstrate that deep-bodied crucian carp attain higher speed, acceleration and turning rate during anti-predator responses than shallow-bodied crucian carp. Therefore, a predator-induced morphology in crucian carp enhances their escape locomotor performance. The deep-bodied carp also show higher percentage of muscle mass. Therefore, their superior performance in escape swimming may be due to a combination of higher muscle power and higher thrust.     

药物滥用者红细胞免疫功能的变化

通过检测红细胞C3b受体花环（RBC－C3bRR)、红细胞免疫复合物光环（RBC－ICR）、粘附增强因子活性（RFER）及抑制因子活性（RFIR）,观察了50例海洛因依赖者红细胞免疫功能的变化。结果表明,海洛因依赖者RBC－C3bRR、RFER明显下降（P＜0．01）,而RBC-ICR、RFIR则明显升高（P＜0．01）。本文对检测结果进行了初步探讨。     

猪瘟病毒反义基因在培养细胞上的效应研究——反义基因对猪瘟病毒的抑制作用

应用免疫荧光抗体技术检测了整合有猪瘟病毒反义基因的PK-15细胞克隆对猪瘟病毒的抑制效应。结果表明,五个不同的反义基因片段对猪瘟病毒的抑制效率存在很大差异,其中A片段的抑制效率最高(94％～98％),B片段次之(58％～76％),C片段再次(～64％),D片段和E片段未见明显的抑制效应。抑制效率的差异可能与反义基因片段的位置、长短以及反义RNA表达质粒载体的差异有关。     

Abortion due to infection with Chlamydia psittaci in a sheep farmer's wife.

A farmer''s wife who had helped with lambing aborted spontaneously in March after a short febrile illness in the 28th week of her pregnancy. She developed disseminated intravascular coagulation post partum with acute renal failure and pulmonary oedema. Recovery was complete after two weeks of hospital care. A strain of Chlamydia psittaci, probably of ovine origin, was isolated from the placenta and fetus. The patient''s serum showed rising titres of antibody against chlamydia group antigen; the placental and fetal isolates; and a known ovine abortion, but not a known avian, strain of C psittaci. IgG against both ovine abortion and enteric strains of C psittaci was detected, but IgM against only an abortion strain was detected. Histological examination showed pronounced intervillus placentitis with chlamydial inclusions in the trophoblast but no evidence of fetal infection or amnionitis. Laboratory evidence of chlamydial infection was found in an aborting ewe on the farm in January and in remaining sheep and lambs in July. Doctors should recognise the possible risk to pregnant women in rural areas where chlamydial infections in farm animals are widespread.     

2 368株自动培养临床分离菌细菌谱分析

目的：了解本地区血(体)液中临床感染细菌的分布情况。方法：采用Mini VITAL全自动荧光血培养仪和VITEK32自动细菌鉴定仪对我院1999年1月～2002年12月临床送检的8362人份16395瓶血(体)液标本的培养结果作回顾性分析。结果：16395瓶临床血(体)液标本需氧和厌氧培养,3894瓶细菌培养阳性,总阳性率23．8％(血液23．2％,体液28．6％),专性厌氧菌占除甲型副伤寒沙门菌外的其他感染菌的3．7％;共检出各种感染菌41属96种2368株,革兰阴性杆菌：革兰阳性球菌：酵母样真菌=86．0：11．8：0．6;有77．3％的兼性厌氧菌同时在需氧和厌氧环境都生长,10．3％和12．4％只在需氧或厌氧培养中生长。结论：除传染病因素外,血(体)液中的感染菌群组成以革兰阳性球菌为主;同时做血(体液)标本的需氧和厌氧培养,可以提高细菌培养阳性率。     

Control of Adenovirus Gene Expression: Cellular Gene Products Restrict Expression of Adenovirus Host Range Mutants in Nonpermissive Cells

Adenovirus type 5 (Ad5) host range mutants dl312 and hr-1, with lesions in region E1A (0 to 4.5 map units) of the viral genome, fail to accumulate virus-specific early RNA during infection in HeLa cells. In a recent report, we showed that the addition of anisomycin, a stringent inhibitor of protein synthesis, at 1 h after infection of HeLa cells with hr-1 virus resulted in the accumulation of properly spliced and translatable mRNA from all early regions (M. G. Katze, H. Persson, and L. Philipson, Mol. Cell. Biol. 1:807-813, 1981). Based on these results we proposed a model in which expression of early mutant RNA was achieved through inactivation of a cellular protein normally causing a reduction in the amount of viral RNA. These studies have been extended in the present report, which shows that early viral proteins can be detected in Ad5 dl312- and Ad5 hr-1-infected HeLa cells which have been treated for several hours with anisomycin either shortly after infection or before infection. A pulse of drug treatment also resulted in expression of substantial amounts of adenovirus structural proteins after infection with both Ad5 hr-1 and Ad5 dl312, whereas in drug-free controls no late proteins were detected. The Ad5 hr-1 virus previously reported to be DNA replication negative in nonpermissive HeLa cells was found to replicate its DNA, albeit at low levels, when anisomycin was present either from 1 to 5 h postinfection or for 5 h before infection. When infectious virus production was examined in mutant-infected cells the titer of Ad5 dl312 virus was found to increase at least 500-fold in anisomycin-treated HeLa cells. Taken together, these and our previous results suggest that the block in gene expression characteristic for complementation group I Ad5 host range mutants in HeLa cells can be overcome by inactivating cellular gene products serving as negative regulators of viral gene expression.